Cargando…

Homoharringtonine suppresses tumor proliferation and migration by regulating EphB4-mediated β-catenin loss in hepatocellular carcinoma

Overexpressed EphB4 conduce to tumor development and is regarded as a potential anticancer target. Homoharringtonine (HHT) has been approved for hematologic malignancies treatment, but its effect on hepatocellular carcinoma (HCC) has not been studied. This study elucidated HHT could restrain the pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Man, Gong, Zhengyan, Wu, Qing, Su, Qi, Yang, Tianfeng, Yu, Runze, Xu, Rui, Zhang, Yanmin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429962/ https://www.ncbi.nlm.nih.gov/pubmed/32801343 http://dx.doi.org/10.1038/s41419-020-02902-2

Ejemplares similares

Low Expression of EphB2, EphB3, and EphB4 in Bladder Cancer: Novel Potential Indicators of Muscular Invasion
por: Lee, Tae Ho, et al.
Publicado: (2021)

EphB/ephrinB Signaling in Cell Adhesion and Migration
por: Park, Inji, et al.
Publicado: (2015)

Reelin induces EphB activation
por: Bouché, Elisabeth, et al.
Publicado: (2013)

The Roles of EphB2 in Cancer
por: Liu, Wei, et al.
Publicado: (2022)

Sanguinarine suppresses migration and metastasis in colorectal carcinoma associated with the inversion of EMT through the Wnt/β‐catenin signaling
por: Zhu, Man, et al.
Publicado: (2020)

EphB2 receptor controls proliferation/migration dichotomy of glioblastoma by interacting with focal adhesion kinase
por: Wang, Shervin D., et al.
Publicado: (2012)

Structure of the EphB6 receptor ectodomain
por: Mason, Emilia O., et al.
Publicado: (2021)

The Differential Expression of EphB2 and EphB4 Receptor Kinases in Normal Bladder and in Transitional Cell Carcinoma of the Bladder
por: Li, Xiuqing, et al.
Publicado: (2014)

EphB4 as a therapeutic target in mesothelioma
por: Liu, Ren, et al.
Publicado: (2013)

Neuropsin cleaves EphB2 in the amygdala to control anxiety
por: Attwood, Benjamin, et al.
Publicado: (2011)

EphB2: potential therapeutic target for Alzheimer’s disease
Publicado: (2011)

Preferential Control of Basal Dendritic Protrusions by EphB2
por: Kayser, Matthew S., et al.
Publicado: (2011)

Paradoxes of the EphB1 receptor in malignant brain tumors
por: Wei, Wenqiang, et al.
Publicado: (2017)

EphB4/EphrinB2 therapeutics in Rhabdomyosarcoma
por: Randolph, Matthew E., et al.
Publicado: (2017)

Key role for EphB2 receptor in kidney fibrosis
por: Huang, Zhimin, et al.
Publicado: (2021)

Knockdown of EphB1 receptor decreases medulloblastoma cell growth and migration and increases cellular radiosensitization
por: Bhatia, Shilpa, et al.
Publicado: (2015)

Differential Roles for EphA and EphB Signaling in Segregation and Patterning of Central Vestibulocochlear Nerve Projections
por: Allen-Sharpley, Michelle R., et al.
Publicado: (2013)

Evaluation of EphA2 and EphB4 as Targets for Image-Guided Colorectal Cancer Surgery
por: Stammes, Marieke A., et al.
Publicado: (2017)

Inhibition of choroidal neovascularization by anti-EphB4 monoclonal antibody
por: SU, DONGFENG, et al.
Publicado: (2013)

EphB4 forward signalling regulates lymphatic valve development
por: Zhang, Gu, et al.
Publicado: (2015)

EphB4 mediates resistance to antiangiogenic therapy in experimental glioma
por: Uhl, Christian, et al.
Publicado: (2018)

EphB2 mediates social isolation-induced memory forgetting
por: Wu, Xin-Rong, et al.
Publicado: (2020)

The EphB6 Receptor: Kinase-Dead but Very Much Alive
por: Strozen, Timothy G., et al.
Publicado: (2021)

EphrinB2–EphB4 Signaling in Neurooncological Disease
por: Piffko, Andras, et al.
Publicado: (2022)

Molecular Determinants of EphA2 and EphB2 Antagonism Enable the Design of Ligands with Improved Selectivity
por: Guidetti, Lorenzo, et al.
Publicado: (2023)

Eph receptor B2 (EPHB2) regulates cancer stem cell-like properties in hepatocellular carcinoma
por: Lim, Jhin Jieh, et al.
Publicado: (2022)

EphB2 activation is required for ependymoma development as well as inhibits differentiation and promotes proliferation of the transformed cell
por: Chen, Phylip, et al.
Publicado: (2015)

miR-204 Regulates Cell Proliferation and Invasion by Targeting EphB2 in Human Cervical Cancer
por: Duan, Shanhong, et al.
Publicado: (2018)

The Recombinant Protein EphB4-Fc Changes the Ti Particle-Mediated Imbalance of OPG/RANKL via EphrinB2/EphB4 Signaling Pathway and Inhibits the Release of Proinflammatory Factors In Vivo
por: Ge, Yu-Wei, et al.
Publicado: (2020)

Investigation of the expression of the EphB4 receptor tyrosine kinase in prostate carcinoma
por: Lee, Yen-Ching, et al.
Publicado: (2005)

Multiple EphB receptor tyrosine kinases shape dendritic spines in the hippocampus
por: Henkemeyer, Mark, et al.
Publicado: (2003)

Involvement of EphB1 Receptors Signalling in Models of Inflammatory and Neuropathic Pain
por: Cibert-Goton, Vincent, et al.
Publicado: (2013)

The composition of EphB2 clusters determines the strength in the cellular repulsion response
por: Schaupp, Andreas, et al.
Publicado: (2014)

Critical roles for EphB and ephrin-B bidirectional signaling in retinocollicular mapping
por: Thakar, Sonal, et al.
Publicado: (2011)

EphB6 overexpression and Apc mutation together promote colorectal cancer
por: Xu, Dan, et al.
Publicado: (2016)

EphB3 signaling propagates synaptic dysfunction in the traumatic injured brain
por: Perez, Enmanuel J., et al.
Publicado: (2016)

Evaluation of EphB4 as Target for Image-Guided Surgery of Breast Cancer
por: de Muijnck, Cansu, et al.
Publicado: (2020)

Prognostic and Clinicopathological Significance of EphB3 and Dysadherin Expression in Extrahepatic Cholangiocarcinoma
por: Wu, Zhengchun, et al.
Publicado: (2020)

The ephrin receptor EphB2 regulates the connectivity and activity of enteric neurons
por: Bodin, Raphael, et al.
Publicado: (2021)

Scaffold Protein Lnx1 Stabilizes EphB Receptor Kinases for Synaptogenesis
por: Li, Na, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r6b7rthu82fjlgl9dt9t4soi8b